These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6437705)

  • 21. Long-term treatment of central precocious puberty with an intranasal LHRH analogue: control of pituitary function by urinary gonadotropins.
    Rime JL; Zumsteg U; Blumberg A; Hadziselimovic F; Girard J; Zurbrügg RP
    Eur J Pediatr; 1988 Apr; 147(3):263-9. PubMed ID: 3134243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
    Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
    J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of male-limited gonadotropin-independent precocious puberty.
    Bertelloni S; Baroncelli GI; Lala R; Cappa M; Matarazzo P; De Sanctis C; Saggese G
    Horm Res; 1997; 48(5):235-9. PubMed ID: 9362394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty.
    Lin TH; LePage ME; Henzl M; Kirkland JL
    J Pediatr; 1986 Dec; 109(6):954-8. PubMed ID: 2946840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simplified gonadotrophin-releasing hormone test for precocious puberty.
    Cavallo A; Richards GE; Busey S; Michaels SE
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):641-6. PubMed ID: 7634506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subcutaneous and intranasal use of a LH-RH analog in the treatment of girls with central precocious puberty].
    Fideleff HL; Boquete HR; Azaretzky M; Damilano S; Cagide AL; Levalle O
    Medicina (B Aires); 1989; 49(6):567-72. PubMed ID: 2518644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central precocious puberty: clinical and laboratory features.
    Chemaitilly W; Trivin C; Adan L; Gall V; Sainte-Rose C; Brauner R
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):289-94. PubMed ID: 11298079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC; de Jong FH; Rose SR; Odink RJ; Bakker-van Waarde WM; Sulkers EJ; Hokken-Koelega AC
    Horm Res; 2009; 71(5):260-7. PubMed ID: 19339790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum bioactive follicle-stimulating hormone levels in girls with precocious sexual development.
    Wang C; Zhong CQ; Leung A; Low LC
    J Clin Endocrinol Metab; 1990 Mar; 70(3):615-9. PubMed ID: 2106526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of precocious puberty using an intranasal luteinizing hormone-releasing hormone analogue: Buserelin.
    Low LC; Wang C; Cheung PT; Chan FL
    Aust Paediatr J; 1989 Oct; 25(5):274-8. PubMed ID: 2511831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of central precocious puberty with an LHRH agonist (Buserelin): effect on growth and bone maturation after three years of treatment.
    Rappaport R; Fontoura M; Brauner R
    Horm Res; 1987; 28(2-4):149-54. PubMed ID: 2969858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The follicle-stimulating hormone (FSH) and luteinizing hormone (LH) response to a gonadotropin-releasing hormone analogue test in healthy prepubertal girls aged 10 months to 6 years.
    Vestergaard ET; Schjørring ME; Kamperis K; Petersen KK; Rittig S; Juul A; Kristensen K; Birkebæk NH
    Eur J Endocrinol; 2017 Jun; 176(6):747-753. PubMed ID: 28348072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteinizing hormone response to clomiphene citrate in central precocious puberty.
    Moreira AC; Castro M; Maciel LM; Hiltner AN
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):73-7. PubMed ID: 1424195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of cryptorchidism with a potent analog of gonadotropin-releasing hormone.
    Happ J; Weber T; Callensee W; Ermert JA; Eshkol A; Beyer J
    Fertil Steril; 1978 May; 29(5):552-6. PubMed ID: 27392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic characteristics of the gonadotropin-releasing hormone analog D-Ser(TBU)-6EA-10luteinizing hormone-releasing hormone (buserelin) after subcutaneous and intranasal administration in children with central precocious puberty.
    Holland FJ; Fishman L; Costigan DC; Luna L; Leeder S
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1065-70. PubMed ID: 3093518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.